Treatment of Kimura Disease With Dupilumab
JAMA Dermatol
.
2022 Mar 1;158(3):329-330.
doi: 10.1001/jamadermatol.2021.5885.
Authors
Yuichi Teraki
1
,
Akane Terao
1
Affiliation
1
Department of Dermatology, Saitama Medical University, Saitama Medical Center, Saitama, Japan.
PMID:
35138349
DOI:
10.1001/jamadermatol.2021.5885
No abstract available
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
Dermatitis, Atopic* / drug therapy
Humans
Kimura Disease*
Treatment Outcome
Substances
Antibodies, Monoclonal, Humanized
dupilumab